NEW YORK – Stilla Technologies announced on Tuesday that it has formed partnerships with 12 new distributors in Europe, the Middle East, and Africa. The agreements allow distribution of the firm's six-color Naica digital PCR platform as well as microfluidic chips and reagents.
The new distributors include: Labgene Scientific in Switzerland; Carlo Erba Reagents in Italy; Bonsai Lab in Portugal and Spain; SEM in Turkey; Explorea in the Czech Republic, Slovakia, and Hungary; Biodynamics in Greece; AH diagnostics in Sweden, Norway, Finland, Denmark, and Baltic countries; Alliance Global in the Gulf, Levant, and African continent, including South Africa, Central Asia, and Pakistan; Danyel Biotech in Israel; Zahrawi Group in Bahrain; TK Biotech in Poland; and Ridacom in Bulgaria.
The applications for the six-color Naica system include cancer and liquid biopsy studies, cell and gene therapies, and infectious disease detection.
"With the expanded global availability of our powerful digital PCR solution, Stilla is answering scientists' demand for faster turnaround time, higher precision, and sensitivity," said Matthew Grow, VP of global marketing and commercial operations at Stilla Technologies. "We are excited to partner with leading distributors who bring deep relationships and a proven history of delivering the most innovative solutions to biomedical researchers and clinicians in their respective territories."
Stilla raised €31.3 million ($34.5 million) in financing last year to expand its global commercial presence.